Your session is about to expire
← Back to Search
Implant
Retrograde Femoral Nail for Broken Bones
N/A
Recruiting
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new type of metal rod implant for fixing broken thigh bones in adults. The goal is to see if this new design helps bones heal better and reduces complications compared to current treatments. Data on healing, function, and pain will be collected over time to evaluate its effectiveness.
Who is the study for?
Adults 18+ with a distal femur or femoral shaft fracture needing surgery can join this trial. They must be treated at UCSD, understand and consent to the study. Excluded are pregnant women, those in other drug studies within the last month, prisoners, and patients with severe diseases not under control.
What is being tested?
The RFN-Advanced Retrograde Femoral Nailing System is being tested for fixing fractures of the lower thigh bone. The study will track how well it works over three years by looking at healing rates, complications, pain levels, and how well patients can use their legs.
What are the potential side effects?
Potential side effects may include issues like malalignment (bones not lining up correctly) which is common with current nail systems used for these types of fractures. Other general surgical risks may apply.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Retrograde Femoral Nail-AdvancedExperimental Treatment1 Intervention
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for femur fractures, particularly distal femur or femoral shaft fractures, involve internal fixation methods such as retrograde femoral nailing. This technique involves inserting a metal rod (nail) into the femur from the knee upwards, which is then secured with screws to stabilize the bone fragments.
The RFN-advanced Retrograde Femoral Nailing System aims to improve alignment and reduce complications such as malalignment and non-union by providing a more stable and precise fixation. This is crucial for patients as it promotes proper healing, reduces pain, and enhances functional recovery, ultimately leading to better long-term outcomes.
[Retrograde intramedullary fixation of distal femoral fractures].
[Retrograde intramedullary fixation of distal femoral fractures].
Find a Location
Who is running the clinical trial?
DePuy SynthesIndustry Sponsor
32 Previous Clinical Trials
4,872 Total Patients Enrolled
University of California, San DiegoLead Sponsor
1,189 Previous Clinical Trials
1,587,833 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My doctor has chosen a specific method to fix my injury.I am 18 years old or older.I need surgery for a broken thigh bone.I do not have any severe illnesses that are not under control.
Research Study Groups:
This trial has the following groups:- Group 1: Retrograde Femoral Nail-Advanced
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.